Brain cancer relapse prediction is an essential area of study, particularly for pediatric patients suffering from brain tumors like gliomas.Recent advancements in artificial intelligence (AI) have paved the way for significantly improved cancer recurrence prediction, allowing for earlier and more accurate assessments of relapse risk.